An asthma medication can bring relief to seasonal asthma sufferers, according to U.S. researchers.
A recent study found that an anti-asthma medication can help children and young adults who suffer from allergic asthma, according to UPI. The study of Xolair or omalizumab, found that the drug dramatically reduces the symptoms of seasonal asthma sufferers when used in conjunction with standard asthma treatments.
Those who received the drug experienced 25 percent fewer days with symptoms and a 30 percent reduction in asthma attacks, said Dr. Rebecca Gruchalla, a study co-author and the chief of allergy and immunology at the University of Texas Southwestern Medical Center in Dallas.
Published in the New England Journal of Medicine, the study found that the drug omalizumab binds to IgE antibodies and inactivates them. IgE antibodies help facilitate asthmatic reactions.
According to Gruchalla, the treatment is currently being used in adults and adolescents with allergic asthma.
